newsfilter
← Latest News
Business Wire·

ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments

Rabbit B Cell Select® Drives Clinical Breakthroughs in Cancer Treatment ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ:IPA), ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ:IPA), an